Neuren Pharmaceuticals (ASX:NEU) Issuance of Debt : A$0.0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Neuren Pharmaceuticals Issuance of Debt?

Neuren Pharmaceuticals's Issuance of Debt for the six months ended in Jun. 2024 was A$0.0 Mil.

Neuren Pharmaceuticals's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2024 was A$0.0 Mil.

Neuren Pharmaceuticals Issuance of Debt Historical Data

The historical data trend for Neuren Pharmaceuticals's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuren Pharmaceuticals Issuance of Debt Chart

Neuren Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Issuance of Debt

Get a 7-Day Free Trial

Neuren Pharmaceuticals Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Issuance of Debt	Get a 7-Day Free Trial															-	-	-	-	-

Neuren Pharmaceuticals Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.0 Mil.

Neuren Pharmaceuticals Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Neuren Pharmaceuticals's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuren Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuren Pharmaceuticals Ltd (ASX:NEU) » Definitions » Issuance of Debt

Comparable Companies

Traded in Other Exchanges

NURPF:USA NK9:Germany

Address

697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.neurenpharma.com

Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.